Sign in
Join
Discovery/Preclinical
In vitro
In vivo
Newer Targets
Clinical
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Phase IV
Recall
Commercial
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Sign up
Welcome!
Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
Search
Sign in / Join
Contact
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Discovery/Preclinical
All
In vitro
In vivo
Newer Targets
Clinical
In one of biotech’s hottest areas and with big partners like…
Clinical
CytoDyn Announces Execution of Exclusive Agreement with American Regent for Distribution…
Commercial
Rexgenero Appoints Dr Gilbert Wagener as Senior Vice President and Chief…
Commercial
Abivax treats first patient in Phase 2b/3 ABX464 Covid-19 clinical trial
Clinical
All
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Phase IV
Recall
Clinical
UK mulls joining EU coronavirus vaccines strategy – FirstWord Pharma
Clinical
Pharma Industry News and Analysis – FirstWord Pharma – Benefits
Clinical
In one of biotech’s hottest areas and with big partners like…
Clinical
Pharma Industry News and Analysis – FirstWord Pharma – Benefits
Commercial
All
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Clinical
Gilead’s Veklury gains conditional EU approval for treatment of COVID-19 –…
Clinical
The European Commission has Granted Orphan Medicinal Product Designation in the…
Clinical
Hydroxychloroquine found to significantly cut death rates in new COVID-19 study…
Clinical
Discovery of new step in how brain cells work could lead…
Home
Therapy areas
Dermatology
Dermatology
Cardio-metabolism
Dermatology
Gastroenterology
Genitourinary
Haematology
Immuno-inflammation
Immuno-oncology
Infectious diseases
Musculoskeletal
Neurology
Nutritional Supplements
Ophthalmology
Orphan-paediatric
Others
Psychiatry
Respiratory
Vaccine
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Dermatology
Vanda Reports results from the EPIONE study of Tradipitant in the treatment of Pruritus in Atopic Dermatitis
Biospace News
-
February 25, 2020
Dermatology
Incyte’s ruxolitinib cream achieves main goal in second late-stage atopic dermatitis study
Firstwordpharma News
-
February 19, 2020
Dermatology
Incyte’s ruxolitinib cream achieves main goal in second late-stage atopic dermatitis...
Firstwordpharma News
-
February 19, 2020
0
Dermatology
Incyte’s Big Dermatitis Week: Ruxolitinib and Baricitinib Hit Primary Endpoints
Biospace News
-
January 28, 2020
0
Dermatology
Incyte’s cream formulation of ruxolitinib hits main goal of late-stage atopic...
Firstwordpharma News
-
January 28, 2020
0
Dermatology
Concert Pharmaceuticals Successfully Completes Open Label Trial of CTP-543 in Patients...
Firstwordpharma News
-
December 19, 2019
0
Dermatology
LEO Pharma’s experimental drug tralokinumab hits main goals of three pivotal...
Firstwordpharma News
-
December 11, 2019
0
1
2
3
...
5
Page 1 of 5
- Advertisement -
LATEST NEWS
Humanigen’s Lenzilumab as a Potential Therapeutic for Lung Damage Arising From Coronavirus
Firstwordpharma News
-
March 9, 2020
0
New Study by Fox Chase Researchers Indicates Neoadjuvant Chemotherapy Does Not Expedite Breast Cancer Treatment
March 2, 2020
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) – March 03, 2020
March 3, 2020
MUST READ
Tele-Rehab Produces Similar Results as In-Clinic Rehabilitation Post Stroke: Presented at ISC
Firstwordpharma News
-
February 11, 2019
0
Arrakis Therapeutics Announces $75 Million Series B Financing to Advance a New Class of...
Firstwordpharma News
-
April 18, 2019
0
Regeneron’s Eylea granted expanded US approval for diabetic retinopathy
Firstwordpharma News
-
May 13, 2019
0
Load more
